How to Buy Petmed Express Stock
Petmed Express Inc
PetMed Express, Inc. , together with its subsidiaries, operates as a pet pharmacy in the United States.
Petmed Express stock last closed at $3.16, up 2.27% from the previous day, and has decreased 21.98% in one year. It has overperformed other stocks in the Pharmaceutical Retailers industry by 0.19 percentage points. Petmed Express stock is currently +8.97% from its 52-week low of $2.90, and -53.87% from its 52-week high of $6.85.
At the moment, there are 20.66M shares of PETS outstanding. The market capitalization of PETS is $65.27M. In the last 24 hours, 181,572 PETS shares were traded.
How to Buy Petmed Express Stock
Not sure how to invest in Petmed Express stock? Here's how.
- Figure out where to buy Petmed Express stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Petmed Express stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Analyze Petmed Express stock: The Petmed Express ticker symbol is PETS. Is Petmed Express stock a good investment? Should you buy shares of PETS? How do PETS's underlying business fundamentals look? Do top analysts think Petmed Express is a good buy? Why has PETS's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PETS is a good stock to buy).
- Execute your PETS trade: Decide if you will purchase PETS shares at the current market price or use a limit order to buy PETS shares at a particular price.
- Keep tabs on your PETS investment: Create a watchlist to keep tabs on your position in Petmed Express shares.
Step 1: Figure out where to buy Petmed Express stock
You need a brokerage account in order to access the NASDAQ market and buy PETS shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you can invest in PETS today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing money into your investment account.
Step 4: Analyze Petmed Express stock
Once you have selected the best place to buy Petmed Express stock, it's important to research their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
Petmed Express stock at a glance
PETS Overview
WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on PETS's stock page.
Is PETS stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PETS's true value.
Using relative valuations ratios:
- PETS could be undervalued based on its P/E ratio of 316x, relative to Pharmaceutical Retailers industry P/E ratio of -0.41x
- PETS could be undervalued based on its P/B ratio of 0.68x, relative to Pharmaceutical Retailers industry P/B ratio of 1.34x
- PETS may be overvalued based on its PEG ratio of 2.13x
You can do additional valuation research on PETS's stock here.
PETS Financials at a glance
Pros:
- PETS earnings of $1.40M is not enough to cover its interest payments.
- There are more short-term assets than long-term liabilities on the PETS balance sheet.
- There are more short-term assets than short-term liabilities on the PETS balance sheet.
- PETS's operating cash flow of $4.83M allows it to safely service it's debt of $1.11M.
- PETS profit margin has gone up from -1% to 0.1% in the past year.
Cons:
- Total PETS debt is higher than 5 years ago, relative to shareholder equity.
- PETS has a relatively high debt to equity ratio of 0.51.
Do Wall Street analysts think it's a good time to buy Petmed Express stock
Out of 1 sell side analysts who give ratings on PETS, the consensus analyst rating on Petmed Express is a Strong Sell
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Petmed Express stock forecast page.
PETS Momentum
PETS Performance Metrics
Last year, PETS earnings were $357.00k. Over the last 5 year, PETS's earnings have grown by -61.93% per year. This was slower than the Pharmaceutical Retailers industry average of -0.42%.
Last year, PETS revenue was $247.01M. Over the past five year, PETS's revenue has increased by -2.08% per year. This was slower than the Pharmaceutical Retailers industry average of 5.67%.
You can research PETS's earnings and revenue performance here.
What are PETS executives and large shareholders up to?
Over the past year, insiders at PETS have bought more shares than they have sold.
Nina Capital Holdings Inc, 10% Owner of PETS, was the latest PETS insider to buy. They bought $408,500.00 worth of PETS shares on Mar 18, 2025.
Get more info about who owns PETS shares here.
Can I get consistent income from PETS stock?
No, Petmed Express doesn't provide an income stream by paying out dividends.
PETS Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your PETS trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, use a limit order.
Hit the Open button and eToro will execute the order.
If you want more help buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your PETS investment
Now that you own some shares in PETS, you'll want to stay up-to-date on your new stock purchase.
Put PETS on a watchlist to keep track of your PETS stock.
PETS Feed
How to Buy Stock in Petmed Express
To reiterate, here are the 6 steps to buy stock in Petmed Express:
- Figure out where to buy Petmed Express stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Petmed Express stock
- Execute your PETS trade
- Keep tabs on your PETS investment
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to track your new investment in Petmed Express, create a watchlist on WallStreetZen today.
Other Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.